Our products benefit from a patented technology that allows the entirely new biocompatible HA-based gel to be easily injected as a fluid gel at room temperature. The fluid phase will enable the practitioner to deliver the product precisely and effortlessly, while using an almost 3 times thinner needle, compared to the nowadays standard.
Consequently, there is a significant decrease in pain for the patient, as well as less bruising.
Once delivered to the desired place, the body temperature will trigger the fluid’s exceptional ability to form microgel structures, increase viscosity and prevent migration.
KYlips will fundamentally improve existing the performance of dermal fillers based on hyaluronic acid especially in the lips enhancement segment where high injectability of the filler is essential.